Scientists Develop New Treatment Option for Multidrug-Resistant Infections
06 June 2019
Tebipenem pivoxil hydrobromide (SPR994)is a new carbapenem being developed by Spero Therapeutics that is being developed as an oral antimicrobial agent. Such a treatment may facilitate earlier discharge from hospital or the possibility of treating complex infections in the community.
Further reading: Infection Control TodaySmart Innovations
Global Ambassador Network
Welcome at the AMR Insights Ambassador Network!
More information and free-of-charge registration
The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).